UA33198A - Method for intensive therapy of schizophrenia - Google Patents

Method for intensive therapy of schizophrenia

Info

Publication number
UA33198A
UA33198A UA99010161A UA99010161A UA33198A UA 33198 A UA33198 A UA 33198A UA 99010161 A UA99010161 A UA 99010161A UA 99010161 A UA99010161 A UA 99010161A UA 33198 A UA33198 A UA 33198A
Authority
UA
Ukraine
Prior art keywords
amitriptyline
haloperidol
oral administration
solution
schizophrenia
Prior art date
Application number
UA99010161A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Original Assignee
Харківська Міська Клінічна Психіатрична Лікарня № 15
Харьковская Городская Клиническая Психиатрическая Больница № 15
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Міська Клінічна Психіатрична Лікарня № 15, Харьковская Городская Клиническая Психиатрическая Больница № 15 filed Critical Харківська Міська Клінічна Психіатрична Лікарня № 15
Priority to UA99010161A priority Critical patent/UA33198A/en
Publication of UA33198A publication Critical patent/UA33198A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

In 30 min after the oral administration of Haloperidol and Amitriptyline in the morning in the setting of preceding two-week oral administration, the rapid tranquilization technique is employed (frequent intramuscular injections of Haloperidol and Amitriptyline, every 1-4 h) until the improvement of the status of the patient with the daily doses from the medium to high followed by the transorbital electrophoresis of 0.5% Haloperidol solution and 1% Amitriptyline solution using two different ocular electrodes with the increment of the current from 2 to 4 mA, the current density from 0.03 to 0.05 mA/cm2. The duration of the procedure increases from 25 to 30 min with the course of the treatment comprising 15 daily procedures.
UA99010161A 1999-01-12 1999-01-12 Method for intensive therapy of schizophrenia UA33198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99010161A UA33198A (en) 1999-01-12 1999-01-12 Method for intensive therapy of schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99010161A UA33198A (en) 1999-01-12 1999-01-12 Method for intensive therapy of schizophrenia

Publications (1)

Publication Number Publication Date
UA33198A true UA33198A (en) 2001-02-15

Family

ID=74196880

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99010161A UA33198A (en) 1999-01-12 1999-01-12 Method for intensive therapy of schizophrenia

Country Status (1)

Country Link
UA (1) UA33198A (en)

Similar Documents

Publication Publication Date Title
ATE114118T1 (en) SYSTEM FOR DRUG DELIVERY BY A TWO-STAGE IONTOPHORESIS PROCESS.
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
KR930700103A (en) (+)-α- (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinemethanol
DE3174924D1 (en) Perioperative application of electronic pain control in combination with anesthetic agents
HUT45247A (en) Process for producing thiazolidinediones with hypolycaemic effect and pharmaceutical compositions comprising the same
WO2003026694A8 (en) Method and apparatus for treatment of viral infection
FR2670491B1 (en) NOVEL 1,4-DISUBSTITUTED PIPERAZINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
UA33198A (en) Method for intensive therapy of schizophrenia
MXPA03005189A (en) Method and apparatus for treating breakthrough pain.
HUP9903679A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
UA33819A (en) Method for treating paranoid shift-like schizophrenia
UA33191A (en) Method for treatment of depressive-paranoid syndrome in schizophrenia patients
UA33739A (en) Method for treating continious schizophrenia
FI962461A (en) Method and pharmaceutical composition for transdermal drug delivery
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
UA33160A (en) Method for intensive therapy of paranoid schizophrenia
AU2001292499A1 (en) 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain
UA38381A (en) METHOD OF COMPLEX THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
JO2296B1 (en) Substituted pyrroles
UA38299A (en) METHOD OF INTENSIVE THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
SE9101341D0 (en) NEW MEDICINAL USE
UA38484A (en) METHOD OF INTENSIVE TREATMENT OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
SU1207472A1 (en) Method and apparatus for local anesthesia
UA22240A (en) Method for complex treatment of patient with paranoid schizophrenia